Comparing the effectiveness of long-term use of daily and weekly glucagon-like peptide-1 receptor agonists treatments in patients with nonalcoholic fatty liver disease and type 2 d...

por Yuan, Xia, Gao, Zhe, Yang, Caixuan, Duan, Kaixin, Ren, Luping, Song, Guangyao
Publicado 2023

Effect of long-acting versus short-acting glucagon-like peptide-1 receptor agonists on improving body weight and related metabolic parameters in type 2 diabetes: A head-to-head met...

por Yuan, Xia, Gao, Zhe, Hao, Zhihua, Ma, Huijuan, Duan, Kaixin, Yang, Caixuan
Publicado 2023